Ph.D. Student, Department of Molecular and Cellular Biology
In the lab: July 2008 - July 2011
Funding: NRSA postdoctoral fellowship, NIH (NIAMS)
Current Position: Postdoctoral Fellow, Isis Pharmaceuticals
Giudice, J, Zheng, X., Wang, E.T., Scavuzzo, M.A., Ward, A.J., Kalsotra, A., Wei, W, Wehrens, X.H.T., Burge, C.B., Li, W. and Cooper, T.A. (2014) Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. Nature Communications. (In Press).
Kalsotra, A., Singh, R.K., Gurha, P., Ward, A.J., Creighton, C. and Cooper, T. A. (2014) The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue dramatically altering miRNA and mRNA expression Cell Reports 6, 336-345. PMC3927417.
Orengo, J.P., Ward, A.J., and Cooper T.A. (2011) Alternative splicing misregulation secondary to skeletal muscle regeneration. Annals Neurology 69, 681-690.
Ward, A.J., Rimer, M., Killian, J.M., Dowling, J.J., Cooper, T.A. (2010) CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum Mol Genet. 19, 3614-3622.
Ward, A.J. and Cooper, T.A. (2010) The pathobiology of alternative splicing. J. Path. 220, 152-163.
Kalsotra, A., Xiao, X., Ward, A.J., Castle, J.C., Johnson, J.M., Burge, C.B., and Cooper, T.A. (2008) A conserved program of regulated alternative splicing during vertebrate heart development. Proc. Nat'l Acad. Sci. 105, 20333-20338.